Accenture (ACN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Achieved Q2 FY25 revenues of $16.7B, up 8.5% in local currency and 5% in USD, with broad-based growth across geographies and industries.
Adjusted Q2 FY25 EPS was $2.82, up 2% year-over-year; GAAP EPS up 7%.
Bookings reached $20.9B, with 32 clients each exceeding $100M in quarterly bookings; bookings were flat in local currency and down 3% in USD.
GenAI momentum continued, with $1.4B in new bookings and $600M in revenue for the quarter.
Workforce grew to 801,000, up from 742,000 a year ago; annualized voluntary attrition remained steady at 13%.
Financial highlights
Revenues grew 8.5% in local currency (5% in USD) to $16.7B; EPS was $2.82, up 2% YoY (adjusted basis).
Operating margin was 13.5%, down 20 bps YoY (adjusted), reflecting higher subcontractor costs and investments.
Free cash flow was $2.7B for Q2 FY25; $3.6B for the first half.
Book-to-bill ratio was 1.3 overall; consulting and managed services both strong.
Cash balance at quarter-end was $8.5B.
Outlook and guidance
Q3 FY25 revenue guidance: $16.9B–$17.5B, 3–7% local currency growth, FX impact -0.5%.
FY25 revenue growth expected at 5–7% in local currency; inorganic contribution just over 3%.
FY25 operating margin expected at 15.6–15.7%, a 10–20 bps expansion YoY (adjusted).
FY25 EPS guidance: $12.55–$12.79, up 5–7% YoY (adjusted).
Free cash flow guidance: $8.8B–$9.5B; plan to return at least $8.3B to shareholders.
Latest events from Accenture
- Q1 FY25 revenue up 9% to $17.7B; FY25 outlook raised, margin at 16.7%, $1.8B returned.ACN
Q1 20259 Jul 2026 - Q3 FY26 revenue grew 6% to $18.7B, with EPS up 9% and strong shareholder returns.ACN
Q3 202618 Jun 2026 - Record bookings, revenue growth, and raised outlook driven by AI and acquisitions.ACN
Q2 20262 May 2026 - AI strategy is evolving rapidly, with ROI, specialization, and change management as top priorities.ACN
Fireside chat18 Mar 2026 - Q3 bookings hit $21.1B, GenAI surged, and FY24 guidance signals steady growth.ACN
Q3 20243 Feb 2026 - Record bookings, margin expansion, and robust FY25 outlook highlight strong momentum.ACN
Q4 202420 Jan 2026 - Revenue up 6%, bookings up 12%, adjusted EPS up 10%, strong cash flow and returns.ACN
Q1 202618 Dec 2025 - Board recommends all proposals amid strong performance, governance, and ESG focus.ACN
Proxy Filing12 Dec 2025 - Board recommends approval of all director, compensation, auditor, and share issuance proposals.ACN
Proxy Filing12 Dec 2025